期刊文献+

Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease 被引量:5

下载PDF
导出
摘要 BACKGROUND Constipation as a most common non-motor symptom of Parkinson's disease(PD),has a higher prevalence compared to the general population.The etiologies of constipation in PD are diverse.In addition to physical weakness and other factors of disease,the lifestyles and eating habits are also important factors.Therefore,the prevalence and influencing factors of constipation may vary among different populations.AIM To determine the prevalence of constipation and analyze relative factors in a cohort of Chinese patients with PD.METHODS All the patients diagnosed with PD according to the movement disorders society criteria were consecutively collected by a self-developed questionnaire.Rome III diagnostic criteria were used to assess functional constipation and Wexner score was used to estimate the severity of constipation.Non-motor symptoms(NMS)were assessed with the non-motor symptoms assessment scale(NMSS).Unified Parkinson's disease Rating Scale III(UPDRS III)was used to evaluate the severity of motor symptoms.The modified Hoehn-Yahr stage was used to evaluate the severity of PD.Cognitive function was assessed using Montreal cognitive assessment(MoCA).Depression and anxiety were rated with the Hamilton depression scale(HAMD)and the Hamilton anxiety scale(HAMA).Quality of life was assessed using the Parkinson’s disease Questionnaire-39 items(PDQ-39).RESULTS Of 166 patients enrolled,87(52.41%)were accompanied with constipation,and 30(34.48%)experienced constipation for 6.30±5.06 years before motor symptoms occurred.Age,Hoehn-Yahr stage,disease duration,levodopa medication times,incidence of motor complications,the scores of UPDRS total,UPDRS III,NMSS,HAMD,HAMA,and PDQ-39 in the constipation group were higher than those in the non-constipation group(P<0.05),but there was no difference in the scores of MoCA,clinical types,or medications between the two groups(P>0.05).There was a higher incidence of depression in patients with constipation(P<0.05),but there were no difference in the incidence of anxiety and cognitive impairment between the two groups(P>0.05).As Hoehn-Yahr stages increased,the severity of constipation increased(P<0.05),but not the incidence of constipation(P>0.05).Pearson correlation analysis showed that constipation was moderately positively correlated with age,Hoehn-Yahr stage,and scores of NMSS,UPDRS III,UPDRS total,PDQ-39,HAMD,and HAMA(r=0.255,0.172,0.361,0.194,0.221,0.237,0.238,and 0.207,P<0.05).Logistic regression analysis showed that only NMSS score was an independent risk factor for constipation(P<0.001).CONCLUSION Our findings confirm that constipation has a relatively high frequency in patients with PD.PD patients with constipation have a higher incidence of depression,which leads to worse quality of life.
出处 《World Journal of Gastrointestinal Pharmacology and Therapeutics》 2021年第1期21-31,共11页 世界胃肠药理与治疗学杂志(英文版)(电子版)
基金 Supported by Key Research and Development Program of Shaanxi Province,China,No.2018SF-016 and No.2020SF-153.
  • 相关文献

参考文献1

二级参考文献20

  • 1Staffan Holmqvist,Oldriska Chutna,Luc Bousset,Patrick Aldrin-Kirk,Wen Li,Tomas Bj?rklund,Zhan-You Wang,Laurent Roybon,Ronald Melki,Jia-Yi Li.Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats[J]. Acta Neuropathologica . 2014 (6)
  • 2W. Y.‐Y. Wu,K.‐H. Kang,S. L.‐S. Chen,S. Y.‐H. Chiu,A. M.‐F. Yen,J. C.‐Y. Fann,C.‐W. Su,H.‐C. Liu,C.‐Z. Lee,W.‐M. Fu,H.‐H. Chen,H.‐H. Liou.Hepatitis C virus infection: a risk factor for P arkinson’s disease[J]. J Viral Hepat . 2015 (10)
  • 3Thomas Clairembault,Laurène Leclair‐Visonneau,Michel Neunlist,Pascal Derkinderen.Enteric glial cells: New players in Parkinson’s disease?[J]. Mov Disord. . 2015 (4)
  • 4Filip Scheperjans,Velma Aho,Pedro A. B. Pereira,Kaisa Koskinen,Lars Paulin,Eero Pekkonen,Elena Haapaniemi,Seppo Kaakkola,Johanna Eerola‐Rautio,Marjatta Pohja,Esko Kinnunen,Kari Murros,Petri Auvinen.Gut microbiota are related to Parkinson’s disease and clinical phenotype[J]. Mov Disord. . 2015 (3)
  • 5Joaquin A. Vizcarra,Hilary E. Wilson‐Perez,Alberto J. Espay.The power in numbers: Gut microbiota in Parkinson’s disease[J]. Mov Disord. . 2015 (3)
  • 6Mayer, Emeran A,Tillisch, Kirsten,Gupta, Arpana.Gut/brain axis and the microbiota[J]. Journal of Clinical Investigation . 2015 (3)
  • 7Coad Thomas Dow.M. Paratuberculosis and Parkinson’s Disease - Is this a Trigger -[J]. Medical Hypotheses . 2014
  • 8Yu-Ting Sui,Kristin M. Bullock,Michelle A. Erickson,Jing Zhang,W.A. Banks.Alpha synuclein is transported into and out of the brain by the blood–brain barrier[J]. Peptides . 2014
  • 9Thomas Clairembault,Willem Kamphuis,Laurène Leclair‐Visonneau,Malvyne Rolli‐Derkinderen,Emmanuel Coron,Michel Neunlist,Elly M. Hol,Pascal Derkinderen.Enteric GFAP expression and phosphorylation in Parkinson’s disease[J]. J. Neurochem. . 2014 (6)
  • 10N. Malek,D. Swallow,K. A. Grosset,O. Anichtchik,M. Spillantini,D. G. Grosset.Alpha‐synuclein in peripheral tissues and body fluids as a biomarker for P arkinson’s disease – a systematic review[J]. Acta Neurol Scand . 2014 (2)

共引文献66

同被引文献51

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部